Ther Clin Risk Manag. 2005 Sep;1(3):181-8.
Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality and contribute to the incidence of adverse events, resulting in increased healthcare costs. Healthcare providers need to understand their role and responsibility in the detection, management, documentation, and reporting of ADRs, all essential activities for optimizing patient safety. The purpose of this article is to summarize findings from important ADR literature reviews and describe the components, and extent of participation, of the national ADR reporting program available in New Zealand. A series of recommendations to increase the detection of ADRs is also described.
药物不良反应（ADR）是发病率和死亡率的重要原因，也是不良事件发生的原因之一，导致医疗保健成本增加。医疗保健提供者需要了解他们在检测、管理、记录和报告 ADR 方面的作用和责任，这些都是优化患者安全的基本活动。本文的目的是总结重要的 ADR 文献综述的结果，并描述新西兰可用的国家 ADR 报告计划的组成部分和参与程度。还描述了一系列增加 ADR 检测的建议。
